These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 17065144

  • 1. Recurrent immune thrombocytopenic purpura in children.
    Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C.
    Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
    [Abstract] [Full Text] [Related]

  • 2. Re: Recurrent immune thrombocytopenic purpura in children.
    Roganovic J, Letica-Crepulja M, Dordevic L.
    Pediatr Hematol Oncol; 2008 Dec; 25(3):243-4. PubMed ID: 18432509
    [No Abstract] [Full Text] [Related]

  • 3. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
    Llamas P, Busto MJ, Díez JL, Cabrera R, Regidor C, Forés R, Sanjuán I, Briz M, Fernández MN.
    Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
    [Abstract] [Full Text] [Related]

  • 4. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
    Dan K, Gomi S, Kuramoto A, Maekawa T, Nomura T.
    Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
    [Abstract] [Full Text] [Related]

  • 5. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
    Schiavotto C, Rodeghiero F.
    Haematologica; 1993 Jun; 78(6 Suppl 2):22-8. PubMed ID: 8039754
    [Abstract] [Full Text] [Related]

  • 6. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N.
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [Abstract] [Full Text] [Related]

  • 7. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C, Castaman G, Rodeghiero F.
    Haematologica; 1993 Aug; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [Abstract] [Full Text] [Related]

  • 8. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.
    Arnal C, Piette JC, Léone J, Taillan B, Hachulla E, Roudot-Thoraval F, Papo T, Schaeffer A, Bierling P, Godeau B.
    J Rheumatol; 2002 Jan; 29(1):75-83. PubMed ID: 11824975
    [Abstract] [Full Text] [Related]

  • 9. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
    Rodeghiero F, Schiavotto C, Castaman G, Vespignani M, Ruggeri M, Dini E.
    Haematologica; 1992 Jan; 77(3):248-52. PubMed ID: 1330848
    [Abstract] [Full Text] [Related]

  • 10. Outcome of chronic idiopathic thrombocytopenic purpura in children.
    Bansal D, Bhamare TA, Trehan A, Ahluwalia J, Varma N, Marwaha RK.
    Pediatr Blood Cancer; 2010 Mar; 54(3):403-7. PubMed ID: 19908301
    [Abstract] [Full Text] [Related]

  • 11. Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China.
    Wang T, Xu M, Ji L, Yang R.
    Acta Haematol; 2006 Mar; 115(1-2):39-45. PubMed ID: 16424648
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto.
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [Abstract] [Full Text] [Related]

  • 13. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
    Dickerhoff R, von Ruecker A.
    J Pediatr; 2000 Nov; 137(5):629-32. PubMed ID: 11060527
    [Abstract] [Full Text] [Related]

  • 14. Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.
    Winde G, Schmid KW, Lügering N, Fischer R, Brandt B, Berns T, Bünte H.
    J Am Coll Surg; 1996 Dec; 183(6):565-74. PubMed ID: 8957458
    [Abstract] [Full Text] [Related]

  • 15. Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia.
    Laws HJ, Janssen G, Borkhardt A.
    Hamostaseologie; 2009 May; 29(2):171-6. PubMed ID: 19404521
    [Abstract] [Full Text] [Related]

  • 16. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 17. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
    Schwartz J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB.
    Am J Hematol; 2003 Feb; 72(2):94-8. PubMed ID: 12555211
    [Abstract] [Full Text] [Related]

  • 18. Outcome of children with idiopathic thrombocytopenic purpura, based on original material.
    Zawitkowska-Klaczyńska J, Nurzyńska-Flak J, Kattski K, Kowalczyk JR.
    Ann Univ Mariae Curie Sklodowska Med; 2004 Feb; 59(2):194-7. PubMed ID: 16146076
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.